Literature DB >> 28387594

Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.

Abeer Sheneef1, Mamdouh M Esmat1, Asmaa N Mohammad2, Aida A Mahmoud3, Hoda M Moghazy4, Amal K Noureldin5.   

Abstract

The aim of the study was to evaluate the association between the gene polymorphisms in interleukin-10 (IL-10) and interferon gamma (IFN-γ) genes with susceptibility and severity of hepatitis C virus (HCV) infection among Egyptian patients. Interleukin-10 -592 A/C, -1082 G/A and IFN-γ +874 T/A genotypes were determined in 100 chronic HCV patients and 50 healthy controls using restriction fragment length polymorphism (RFLP) and the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) respectively. IL-10 -592 A/C polymorphism genotyping revealed that the frequency of CC genotype was significantly higher in chronic HCV patients than in controls (58% versus 30%, P < 0.05). Regarding IL-10 -1082 G/A polymorphism genotyping, a higher frequency of GG genotype was found in chronic HCV patients compared to controls (31% versus 10%, P < 0.05). IFN-γ +874 T/A genotyping showed that TT genotype was significantly higher in chronic HCV participants than controls (31% versus 18%, P < 0.05), while a higher frequency of T allele was found in cirrhotic patients compared to noncirrhotic patients (P < 0.05). Our observations suggested that IL-10 -592 A/C, -1082 G/A, and IFN-γ +874 T/A polymorphisms had a strong association with susceptibility to HCV infection. However, no significant association was observed between the cytokines (IL-10 and IFN-γ) genotypes profile and HCV-liver cirrhosis risk in the studied population, except for the high frequency of IFN-γ +874 T allele in cirrhotic patients.

Entities:  

Keywords:  gene polymorphism; hepatitis C virus; interferon-γ; interleukin-10

Mesh:

Substances:

Year:  2017        PMID: 28387594     DOI: 10.1089/jir.2016.0106

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  4 in total

1.  IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis.

Authors:  Minghui Zheng; Weizhen Fang; Menglei Yu; Rui Ding; Hua Zeng; Yan Huang; Yuanyang Mi; Chaohui Duan
Journal:  BMC Endocr Disord       Date:  2021-12-09       Impact factor: 2.763

2.  TNFA -308G>A and IL10 -1082A>G polymorphisms seem to be predictive biomarkers of chronic HCV infection.

Authors:  Angélica Menezes Santiago; Ednelza da Silva Graça Amoras; Maria Alice Freitas Queiroz; Simone Regina Souza da Silva Conde; Izaura Maria Vieira Cayres-Vallinoto; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2021-11-03       Impact factor: 3.090

3.  Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.

Authors:  Xing-Zhizi Wang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2018-02-19

4.  High expression of FAM13A was associated with increasing the liver cirrhosis risk.

Authors:  Yingai Zhang; Shunlan Wang; Chan Wang; Jingchuan Xiao; Shufang Zhang; Hailong Zhou
Journal:  Mol Genet Genomic Med       Date:  2019-01-02       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.